Percutaneous Impella RP use for refractory right heart failure in adolescents and young adults—A multicenter U.S. experience
- 4 March 2020
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 96 (2) , 376-381
Abstract
Objective: To assess the outcomes of the use of the percutaneous Impella RP device (Abiomed, Danvers, MA) in adolescents and young adults.Background: Results of the Impella RP device have been reported in adults, but a multicenter experience in adolescents and young adults has yet to be reported.Methods: Patients ≤21 years of age who underwent implantation of an Impella RP device for refractory right heart failure from June, 2016 to April, 2018 at nine U.S. Centers were included.Results: A total of 12 adolescents, median age of 18 (14–21) years and median weight 74.4 (49–112.4) kg underwent Impella RP implantation (INTERMACS Profile 1 in nine and Profile 2 in three patients. The central venous pressure decreased from 20 (16–35) to 12 (7–17) mmHg, (p = .001). One patient was concomitantly supported with an intra‐aortic balloon pump (IABP) and the rest with a percutaneous/surgically placed left ventricular assist device. There was one adverse event related to the Impella RP device (thrombosis requiring explant). The support duration was 6.5 days (4.8 hr–18.4 days) and survival to hospital discharge was 83%. At a median follow‐up of 11 months (5 days–2.5 years), 8 of 12 (67%) patients are alive.Conclusions: In this multicenter experience, the Impella RP device was found to be efficacious and safe when used in adolescents and young adults. Further studies are warranted to identify suitable young/pediatric candidates for Impella RP therapy for right heart failure.Keywords
This publication has 12 references indexed in Scilit:
- First Report of Biventricular Percutaneous Impella Ventricular Assist Device Use in Pediatric PatientsASAIO Journal, 2018
- Percutaneous Mechanical Circulatory Support Using Impella Devices for Decompensated Cardiogenic Shock: A Pediatric Heart Center ExperienceASAIO Journal, 2018
- A multicenter study of the impella device for mechanical support of the systemic circulation in pediatric and adolescent patientsCatheterization and Cardiovascular Interventions, 2017
- Circulatory support using the impella device in fontan patients with systemic ventricular dysfunction: A multicenter experienceCatheterization and Cardiovascular Interventions, 2017
- Supporting pediatric patients with short-term continuous-flow devicesThe Journal of Heart and Lung Transplantation, 2016
- Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP deviceThe Journal of Heart and Lung Transplantation, 2015
- 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular CareJACC, 2015
- The RECOVER I: A multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory supportThe Journal of Thoracic and Cardiovascular Surgery, 2013
- A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary InterventionCirculation, 2012
- A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial)JACC: Cardiovascular Interventions, 2009